Skip to main content
Clinical Trials/NCT02915328
NCT02915328UnknownNot Applicable

Role of the Type of Carotid Stent and Cerebral Protection on Cerebral Microembolization During Carotid Artery Stenting. A Randomized Study Comparing Carotid Wallstent vs Roadsaver® Stent and Distal vs Proximal Protection.

Centro Cardiologico Monzino2 sites in 1 country100 target enrollmentStarted: April 1, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Sponsor
Enrollment
100
Locations
2
Primary Endpoint
number of microembolization signals (MES) detected with transcranial doppler

Study Overview

Brief Summary

Stenting is an alternative to traditional surgery in the treatment of carotid stenosis.The intra and/or postprocedural cerebral embolization remains the most frequent complication.

The type of carotid stent and of cerebral protection are the two most important variables potentially affecting the rate of cerebral microembolization. So far there no consensus on the the best stent and cerebral protection.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • significant, unilateral carotid artery stenosis with soft plaque defined as:
  • symptomatic patients: > 1.3 m/sec peak systolic velocity and > 50% diameter stenosis by Doppler ultrasound and < 60 hounsfield unit by CT angiography
  • asymptomatic patients > 2.5 m/sec peak systolic velocity and > 70% diameter stenosis by Doppler ultrasound and < 60 hounsfield unit by CT angiography

Exclusion Criteria

  • severe cerebral vasculopathy with cognitive impairment
  • contraindication to double antiplatelet treatment
  • controlateral carotid occlusion

Outcomes

Primary Outcomes

number of microembolization signals (MES) detected with transcranial doppler

Time Frame: intraprocedural

different phases of carotid stenting (lesion wiring; predilation; stent crossing of the lesion; stent deployment; stent post dilation; device retrieval/deflation

Secondary Outcomes

  • 6 month clinical follow up(6 month)
  • Doppler ultrasound assesment(day 2 or day 3, 1 month and 6 month)
  • Clinical success(day 2 or day 3 and day 30 complication)

Investigators

Sponsor
Centro Cardiologico Monzino
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Piero Montorsi

MD

Centro Cardiologico Monzino

Study Sites (2)

Loading locations...

Similar Trials

Role of the Type of Carotid Stent and... | Clinical Trial